Author Correction: The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation

• Morris Nechama,
• Jeahoo Kwon,
• Shuo Wei,
• Adrian Tun-Kyi,
• Robert S. Welner,
• Iddo Z. Ben-Dov,
• Mohamed S. Arredouani,
• John M. Asara,
• Chun-Hau Chen,
• Cheng-Yu Tsai,
• Kyle F. Nelson,
• Koichi S. Kobayashi,
• Elliot Israel,
• Xiao Zhen Zhou,
• Linda K. Nicholson,
• Kun Ping Lu

Affiliations

Morris Nechama

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Jeahoo Kwon

Department of Molecular Biology & Genetics, Cornell University

Shuo Wei

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Adrian Tun-Kyi

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Robert S. Welner

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Iddo Z. Ben-Dov

Department of Nephrology and Hypertension, Hadassah-Hebrew Medical Center

Mohamed S. Arredouani

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

John M. Asara

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Chun-Hau Chen

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Cheng-Yu Tsai

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Kyle F. Nelson

Department of Medicine, Brigham and Women’s Hospital

Koichi S. Kobayashi

Department of Microbial Pathogenesis & Immunology, Texas A&M Health Science Center

Elliot Israel

Department of Medicine, Brigham and Women’s Hospital

Xiao Zhen Zhou

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School

Linda K. Nicholson

Department of Molecular Biology & Genetics, Cornell University

Kun Ping Lu

Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School